Page last updated: 2024-08-05 11:27:42
iminium betaine
null
ChEBI ID: 35285
Members (6)
Member | Definition | Role |
---|---|---|
nicotine n-glucuronide | An N-glycosylpyridine that is the N-alpha-D-glucosiduronyl derivative of (S)-nicotine. | (S)-nicotinium N-alpha-D-glucosiduronate |
ppi-0903 | A cephalosporin having [4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl and {(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino side groups located at positions 3 and 7 respectively. The N-phospho prodrug of ceftaroline, a broad-spectrum antibiotic active against methicillin-resistant Staphylococcus aureus (MRSA). It is used for the treatment of adults with acute bacterial skin and skin structure infections. | ceftaroline fosamil |
pyocyanine | An iminium betaine that is 5-methylphenazin-5-ium which is substituted at position 1 by an oxidanidyl group. An antibiotic pigment produced by Pseudomonas aeruginosa. | pyocyanine |
pyrostatin a | An iminium betaine resulting from a transfer of a proton from the carboxy group to the imino group of 5-hydroxyectoine. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.). | 5-hydroxyectoine zwitterion; 5-hydroxyectoine |
serpentine (alkaloid) | An indole alkaloid that is 18-oxayohimban dehydrogenated at positions 3, 4, 5, 6, 16 and 17 and substituted by a methyl group at the 19alpha position and by a methoxycarbonyl group at position 16. | serpentine |
trigonelline | An iminium betaine that is the conjugate base of N-methylnicotinic acid, arising from deprotonation of the carboxy group. | N-methylnicotinate |
Research
Studies (1,600)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 121 (7.56) | 18.7374 |
1990's | 86 (5.38) | 18.2507 |
2000's | 217 (13.56) | 29.6817 |
2010's | 881 (55.06) | 24.3611 |
2020's | 295 (18.44) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 53 (3.21%) | 5.53% |
Reviews | 108 (6.55%) | 6.00% |
Case Studies | 52 (3.15%) | 4.05% |
Observational | 10 (0.61%) | 0.25% |
Other | 1,426 (86.48%) | 84.16% |